<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The principal metabolic effect of <z:chebi fb="0" ids="6801">metformin</z:chebi>-an oral antihyperglycaemic agent-is the improvement in the sensitivity of peripheral tissues and liver to insulin </plain></SENT>
<SENT sid="1" pm="."><plain>This study examined the effect of <z:chebi fb="0" ids="6801">metformin</z:chebi> monotherapy on antioxidative defence system activity in erythrocytes and plasma in diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the effect of <z:chebi fb="0" ids="6801">metformin</z:chebi> treatment on the activities of Cu, Zn-<z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (EC 1 </plain></SENT>
<SENT sid="3" pm="."><plain>15 </plain></SENT>
<SENT sid="4" pm="."><plain>1 </plain></SENT>
<SENT sid="5" pm="."><plain>1.), catalase (EC 1 </plain></SENT>
<SENT sid="6" pm="."><plain>11 </plain></SENT>
<SENT sid="7" pm="."><plain>1 </plain></SENT>
<SENT sid="8" pm="."><plain>6.) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (EC 1 </plain></SENT>
<SENT sid="9" pm="."><plain>11 </plain></SENT>
<SENT sid="10" pm="."><plain>1 </plain></SENT>
<SENT sid="11" pm="."><plain>9.) in relation to <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation products and reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> level in plasma and erythrocytes </plain></SENT>
<SENT sid="12" pm="."><plain>In this study we also examined erythrocytes' susceptibility to <z:chebi fb="0" ids="30492">H2O2</z:chebi>-induced <z:mp ids='MP_0003674'>oxidative stress</z:mp> during <z:chebi fb="0" ids="6801">metformin</z:chebi> therapy </plain></SENT>
<SENT sid="13" pm="."><plain>Although <z:chebi fb="0" ids="6801">metformin</z:chebi> monotherapy ameliorated the imbalance between free radical-induced increase in <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation (by reducing the <z:chebi fb="14" ids="32506">MDA</z:chebi> level in both erythrocytes and plasma) and decreased plasma and cellular <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defences (by increasing the erythrocyte activities of Cu, Zn, SOD, catalase and GSH level) and decreased erythrocyte susceptibility to <z:mp ids='MP_0003674'>oxidative stress</z:mp>, it had negligible effect to scavenge Fe ion-induced free radical generation in a <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-liposome system </plain></SENT>
</text></document>